Export 469 results:
[ Author(Desc)] Title Type Year
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S. Takenoshita, Terada, S., Yokota, O., Kutoku, Y., Wakutani, Y., Nakashima, M., Maki, Y., Hattori, H., and Yamada, N., Sally-Anne Test in Patients with Alzheimer's Disease Dementia., J Alzheimers Dis, vol. 61, no. 3, pp. 1029-1036, 2018.
K. Talbot, Wang, H. - Y., Kazi, H., Han, L. - Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., Arvanitakis, Z., Schneider, J. A., Wolf, B. A., Bennett, D. A., Trojanowski, J. Q., and Arnold, S. E., Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline., J Clin Invest, vol. 122, no. 4, pp. 1316-38, 2012.
M. T. Tam, Dosso, J. A., and Robillard, J. M., The Impact of a Global Pandemic on People Living with Dementia and Their Care Partners: Analysis of 417 Lived Experience Reports., J Alzheimers Dis, vol. 80, no. 2, pp. 865-875, 2021.
C. - C. Tan, Wan, Y., Tan, M. - S., Zhang, W., Wang, Z. - X., Sun, F. - R., Miao, D., Tan, L., and Yu, J. - T., Association of Frontotemporal Dementia GWAS Loci with Late-Onset Alzheimer's Disease in a Northern Han Chinese Population., J Alzheimers Dis, vol. 52, no. 1, pp. 43-50, 2016.
Q. Tao, Zhu, H., Chen, X., Stern, R. A., Kowall, N., Au, R., Blusztajn, J. Krzysztof, and Qiu, W. Qiao, Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease., J Alzheimers Dis, vol. 62, no. 2, pp. 597-609, 2018.
P. N. Tariot, Braeckman, R., and Oh, C., Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil., J Alzheimers Dis, vol. 90, no. 1, pp. 161-172, 2022.
S. J. Teipel, Dyrba, M., Ballarini, T., Brosseron, F., Bruno, D., Buerger, K., Cosma, N. - C., Dechent, P., Dobisch, L., Düzel, E., Ewers, M., Fliessbach, K., Haynes, J. D., Janowitz, D., Kilimann, I., Laske, C., Maier, F., Metzger, C. D., Munk, M. H., Peters, O., Pomara, N., Preis, L., Priller, J., Rámirez, A., Roy, N., Scheffler, K., Schneider, A., Schott, B. H., Spottke, A., Spruth, E. J., Wagner, M., Wiltfang, J., Jessen, F., and Heneka, M. T., Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum., J Alzheimers Dis, vol. 85, no. 3, pp. 1267-1282, 2022.
R. Thangavel, Bhagavan, S. M., Ramaswamy, S. Beladakere, Surpur, S., Govindarajan, R., Kempuraj, D., Zaheer, S., Raikwar, S., Ahmed, M. E., Selvakumar, G. Pushpavath, Iyer, S. S., and Zaheer, A., Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain., J Alzheimers Dis, vol. 61, no. 2, pp. 553-560, 2018.
A. Ticinesi, Mancabelli, L., Carnevali, L., Nouvenne, A., Meschi, T., Del Rio, D., Ventura, M., Sgoifo, A., and Angelino, D., Interaction Between Diet and Microbiota in the Pathophysiology of Alzheimer's Disease: Focus on Polyphenols and Dietary Fibers., J Alzheimers Dis, vol. 86, no. 3, pp. 961-982, 2022.
S. Tok, Ahnaou, A., and Drinkenburg, W., Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression., J Alzheimers Dis, vol. 88, no. 3, pp. 809-836, 2022.
M. Tong, Deochand, C., Didsbury, J., and de la Monte, S. M., T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 123-38, 2016.
S. Toniolo, Scarioni, M., Di Lorenzo, F., Hort, J., Georges, J., Tomic, S., Nobili, F., and Frederiksen, K. Steen, Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care., J Alzheimers Dis, vol. 82, no. 3, pp. 883-898, 2021.
G. Tosto, Monsell, S. E., Hawes, S. E., Bruno, G., and Mayeux, R., Progression of Extrapyramidal Signs in Alzheimer's Disease: Clinical and Neuropathological Correlates., J Alzheimers Dis, vol. 49, no. 4, pp. 1085-93, 2016.
A. Tramutola, Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., Broekaart, D., Blarzino, C., Head, E., D Butterfield, A., and Perluigi, M., Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype., J Alzheimers Dis, vol. 52, no. 1, pp. 359-71, 2016.
J. C. Triplett, Swomley, A. M., Cai, J., Klein, J. B., and D Butterfield, A., Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease., J Alzheimers Dis, vol. 49, no. 1, pp. 45-62, 2016.
H. - H. Tsou, Hsu, W. - C., Fuh, J. - L., Chen, S. - P., Liu, T. - Y., and Wang, H. - T., Alterations in Acrolein Metabolism Contribute to Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 571-580, 2018.
A. Tsugawa, Sakurai, S., Inagawa, Y., Hirose, D., Kaneko, Y., Ogawa, Y., Serisawa, S., Takenoshita, N., Sakurai, H., Kanetaka, H., Hirao, K., and Shimizu, S., Awareness of the COVID-19 Outbreak and Resultant Depressive Tendencies in Patients with Severe Alzheimer's Disease., J Alzheimers Dis, vol. 77, no. 2, pp. 539-541, 2020.
A. Tucholka, Grau-Rivera, O., Falcon, C., Rami, L., Sánchez-Valle, R., Lladó, A., Gispert, J. Domingo, and Molinuevo, J. Luis, Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and Tau., J Alzheimers Dis, vol. 61, no. 4, pp. 1575-1587, 2018.
C. Tuena, Mancuso, V., Stramba-Badiale, C., Pedroli, E., Stramba-Badiale, M., Riva, G., and Repetto, C., Egocentric and Allocentric Spatial Memory in Mild Cognitive Impairment with Real-World and Virtual Navigation Tasks: A Systematic Review., J Alzheimers Dis, vol. 79, no. 1, pp. 95-116, 2021.
O. Turró-Garriga, Garre-Olmo, J., Calvó-Perxas, L., Reñé-Ramírez, R., Gascón-Bayarri, J., and Conde-Sala, J. Lluís, Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up., J Alzheimers Dis, vol. 51, no. 2, pp. 357-66, 2016.